Plain-English translation of NCT07249905 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lymphoma research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it can help treat B-cell lymphomas that have come back or stopped responding to previous treatments. Researchers want to find the right dose of this medication and understand how well it works and how safe it is for different types of lymphoma. You would receive the medication as an intravenous infusion (through an IV).
Many people with B-cell lymphomas eventually find that standard treatments stop working, leaving them with limited options. This trial is exploring whether this new medication could offer hope to patients whose cancer has returned or resisted previous treatments.
You likely qualify if…
You likely don't qualify if…
You would visit the study center to receive as an intravenous infusion. The trial has two parts: first, researchers test increasing doses to find the safest and most effective dose; then, they expand the study with that dose in people with specific types of lymphoma. Throughout the trial, you would have blood tests, imaging scans, and checkups to monitor how you are responding and to watch for any side effects.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
Australia